<DOC>
	<DOC>NCT02776982</DOC>
	<brief_summary>This study is being done to help understand why some people with an increased amount of central obesity, without gastroesophageal reflux, develop changes to the lining of their esophagus that can potentially lead to esophageal adenocarcinoma (cancer).</brief_summary>
	<brief_title>Influence of Central Obesity on the Esophageal Epithelial Barrier</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Obesity, Abdominal</mesh_term>
	<criteria>Participants who are undergoing clinically indicated 24hour ambulatory impedance pH monitoring (off reflux medications for 7 days), in the Esophageal Function Laboratory at Mayo Clinic, followed by endoscopy within 2496 hours. 1. Preexisting or suspected Barrett's Esophagus (&gt; 1cm of columnar mucosa in esophagus on endoscopy 2. Oral anticoagulation precluding endoscopic biopsies 3. Patients with known hypersensitivity to fluorescein sodium.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Barrett's Esophagus</keyword>
	<keyword>Esophageal adenocarcinoma</keyword>
</DOC>